April 19, 2005: Canada is the first country in the world to license a plant-based cannabinoid pharmaceutical medicine, Sativex, created by GW Pharmaceuticals and marketed in conjunction with Bayer. It's to relieve nerve pain for those especially with MS. Sativex is a combination of plant-derived delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The ratio of THC to CBD in Sativex is 2.7 mg to 2.5 mg per spray, which ensures a standardized dose is delivered each time it is used. It?s administered via a spray pump which places Sativex spray under the tongue or on the inside of the cheek.........So I wonder how long before the States approves it----or will George Dubya sign a Bill saying that Marijuana is from de Debbil and refuse to let the Yanks use it.......for anyone who does need it, there are pharmacies in Ontario and Quebec that will fill American prescriptions (even though they're not supposed to) at about 1/4 the price you'd pay for it in the States.
On the lighter side, some names that were considered for this new drug, but never made it, were:
Weed-a-bix
I-be-puffin
Dude, Where's My Drugs?!